2000
DOI: 10.1016/s0167-7799(99)01416-x
|View full text |Cite
|
Sign up to set email alerts
|

Gene therapy: the first decade

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
214
0
9

Year Published

2000
2000
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 303 publications
(223 citation statements)
references
References 75 publications
0
214
0
9
Order By: Relevance
“…The ability to correct these genetic defects would provide an advancement in the treatment of diseases caused by genetic malfunctions (Friedmann and Roblin 1972). Gene therapy is a promising strategy of treating diseases at a genetic level by introducing genes to a target cell in order to correct, restore, modify or enhance cellular activities (Mountain 2000;Nathwani, Benjamin et al 2004). Gene therapy employs nucleic acid to prevent or treat acquired diseases such as cancer (McNeish, Bell et al 2004), neurological diseases (Ribotta 2001), cardiovascular diseases (Katz, Swain et al 2010) or inherited diseases such as muscular dystrophy (Inui, Okada et al 1996) or cystic fibrosis (Griesenbach, Geddes et al 2006).…”
Section: Introductionmentioning
confidence: 99%
“…The ability to correct these genetic defects would provide an advancement in the treatment of diseases caused by genetic malfunctions (Friedmann and Roblin 1972). Gene therapy is a promising strategy of treating diseases at a genetic level by introducing genes to a target cell in order to correct, restore, modify or enhance cellular activities (Mountain 2000;Nathwani, Benjamin et al 2004). Gene therapy employs nucleic acid to prevent or treat acquired diseases such as cancer (McNeish, Bell et al 2004), neurological diseases (Ribotta 2001), cardiovascular diseases (Katz, Swain et al 2010) or inherited diseases such as muscular dystrophy (Inui, Okada et al 1996) or cystic fibrosis (Griesenbach, Geddes et al 2006).…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] Lentiviral vectors have the unique feature of being able to transduce nondividing cells, making it particularly attractive for certain gene therapy applications. [5][6][7] Sometimes, to achieve a desirable therapeutic effect, the viral vectors must be capable of precisely delivering a gene of interest to specific cells without influencing non-target cells.…”
Section: Introductionmentioning
confidence: 99%
“…The generation of high titer and quality retroviral vector (RV) preparations are currently critical issues in gene therapy clinical applications [1,2].…”
Section: Introductionmentioning
confidence: 99%